Clinical Trial Update: Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of NMD670 in adult patients with Charcot-Marie-Tooth disease types 1 and 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type

Drugs mentioned

• NMD670

Snippet

Sponsor: NMD Pharma A/S | Conditions: Charcot-Marie-Tooth Disease | Phase 2 | Status: COMPLETED